Skip to content

Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)

Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03369249
Enrollment
307
Registered
2017-12-11
Start date
2017-12-09
Completion date
2022-12-01
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS, HIV Infections, Sexually Transmitted Diseases, Substance Abuse, Substance Use, Substance Use Disorders

Brief summary

This research study proposes to embed HIV testing outreach workers from a young adult focused medical and HIV treatment program into an alternative sentencing program to deliver a new service delivery model (Link2CARE) that integrates evidence-based protocols for justice-involved young adults to: a) promote HIV and STI testing, and HIV and SU risk screening, b) provide onsite intervention, and c) cross-system linkage to HIV, STI, and SU care. Phase 1 has already been completed. In phase 1, the intervention components were adapted for use among justice involved young adults and the resulting protocols were piloted with justice involved young adults, finalizing the resulting 4-session Link2CARE intervention. In phase 2, we will test Link2CARE among N=450 justice-involved young adults enrolled at the alternative sentencing program and conduct process evaluations with N=15 alternative sentencing program staff.

Interventions

BEHAVIORALLink2CARE

The Link2CARE intervention consists of 4 sessions. Session 1 consists of a one-on-one meeting with a Health Coach, during which participants will be offered an oral rapid HIV test and STI test. Sessions 2, 3, and 4 are group-based. During these sessions, participants will engage in discussions and activities regarding sexual and substance use risk behaviors.

Sponsors

Center for Court Innovation
CollaboratorOTHER
The National Center on Addiction and Substance Abuse at Columbia University
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Columbia University
CollaboratorOTHER
New York State Psychiatric Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Young Adults Inclusion Criteria: * Between 18-24 years of age * Currently enrolled at the alternative to sentencing program * Conversant in English * Engaged in any unprotected or vaginal sexual activity (in the past 12 months)

Exclusion criteria

* Cognitively unable to complete the interview * HIV positive Alternative to Sentencing Staff Inclusion Criteria: * Currently employed at the alternative to sentencing program * Between ages of 18-80

Design outcomes

Primary

MeasureTime frameDescription
Total Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Monthsat 12-month follow-upmeasured by participant report in the Sexual Risk section of the questionnaires

Secondary

MeasureTime frameDescription
Number of Young Adults Referred to Substance Use Treatmentat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the Substance Use Referral section of the questionnaires
Number of STI+ Young Adults Referred to STI Treatmentat 3-, 6-, and 12-month follow-upsmeasured by the Health Coach report in the Health Coach Logs and participant report in the STI Referral section of the questionnaires
Number of STI+ Young Adults Attending 1 or More Treatment Appointmentsat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the STI Treatment section of the questionnaires
Acceptance of HIV Testing (Yes/no)at day 1 of enrollmentmeasured by Health Coach report in the Session 1 Sexual Risk questionnaire
Any HIV Testingbetween 6-month and 12-month follow-upsmeasured by participant report in the HIV Testing section of the questionnaires
Any STI Testingbetween 6- and 12-month follow-upsmeasured by participant report in the STI Testing section of the questionnaires
Number of Young Adults Attending Intake Plus One Treatment Sessionat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the Substance Use Treatment section of the questionnaires
Frequency of Young Adults Substance Use in Past 30 Daysat 3-, 6-, and 12-month follow-upsmeasured by participant report in the Substance Use section of the questionnaires
Acceptance of STI Testing (Yes/no)at day 1 of enrollmentmeasured by Health Coach report in the Session 1 Sexual Risk questionnaire

Other

MeasureTime frameDescription
Number of Young Adults Behaviorally PrEP Eligible Referred to PrEP/Medical Careat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the PrEP Referral section of the questionnaires
Number of Young Adults Behaviorally PrEP Eligible Attending at Least One HIV Care Appointmentat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the PrEP Uptake section of the questionnaires
Number of HIV+ Young Adults Attending at Least One Treatment Appointmentat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the HIV Treatment section of the questionnaires
Number of HIV+ Young Adults Referred to HIV Treatmentat 3-, 6-, and 12-month follow-upsmeasured by Health Coach report in the Health Coach logs and participant report in the HIV Referral section of the questionnaires

Countries

United States

Participant flow

Recruitment details

participants were recruited at the County Court house; screening took place and if eligible the participant was scheduled an appointment for baseline survey and randomized to study group. The first session either happened the same day or a few days later if the participant was unable to stay following the survey

Participants by arm

ArmCount
Link2CARE
This arm is comprised of participants randomized to the 4-session Link2CARE intervention. Link2CARE: The Link2CARE intervention consists of 4 sessions. Session 1 consists of a one-on-one meeting with a Health Coach, during which participants will be offered an oral rapid HIV test and STI test. Sessions 2, 3, and 4 are group-based. During these sessions, participants will engage in discussions and activities regarding sexual and substance use risk behaviors.
152
Standard of Care
This arm is comprised of participants who will not receive the 4-session Link2CARE intervention.
155
Total307

Baseline characteristics

CharacteristicStandard of CareTotalLink2CARE
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
155 Participants307 Participants152 Participants
Age, Continuous21.02 years
STANDARD_DEVIATION 2.08
21.13 years
STANDARD_DEVIATION 2.06
21.23 years
STANDARD_DEVIATION 2.04
Race (NIH/OMB)
American Indian or Alaska Native
11 Participants13 Participants2 Participants
Race (NIH/OMB)
Asian
1 Participants5 Participants4 Participants
Race (NIH/OMB)
Black or African American
103 Participants203 Participants100 Participants
Race (NIH/OMB)
More than one race
27 Participants62 Participants35 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants3 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants2 Participants1 Participants
Race (NIH/OMB)
White
11 Participants19 Participants8 Participants
Region of Enrollment
United States
155 participants307 participants152 participants
Sex: Female, Male
Female
37 Participants78 Participants41 Participants
Sex: Female, Male
Male
118 Participants229 Participants111 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1521 / 155
other
Total, other adverse events
24 / 15225 / 155
serious
Total, serious adverse events
0 / 1520 / 155

Outcome results

Primary

Total Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Months

measured by participant report in the Sexual Risk section of the questionnaires

Time frame: at 12-month follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Link2CARETotal Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Months12months27.70 unprotected sex occasionsStandard Deviation 57.43
Link2CARETotal Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Monthsbaseline32.76 unprotected sex occasionsStandard Deviation 60.44
Standard of CareTotal Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Monthsbaseline44.00 unprotected sex occasionsStandard Deviation 76.65
Standard of CareTotal Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Months12months32.76 unprotected sex occasionsStandard Deviation 73.37
p-value: 0.63595% CI: [-0.46, 0.75]generalized estimating equations
Secondary

Acceptance of HIV Testing (Yes/no)

measured by Health Coach report in the Session 1 Sexual Risk questionnaire

Time frame: at day 1 of enrollment

Secondary

Acceptance of STI Testing (Yes/no)

measured by Health Coach report in the Session 1 Sexual Risk questionnaire

Time frame: at day 1 of enrollment

Secondary

Any HIV Testing

measured by participant report in the HIV Testing section of the questionnaires

Time frame: between 6-month and 12-month follow-ups

Secondary

Any STI Testing

measured by participant report in the STI Testing section of the questionnaires

Time frame: between 6- and 12-month follow-ups

Secondary

Frequency of Young Adults Substance Use in Past 30 Days

measured by participant report in the Substance Use section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Secondary

Number of STI+ Young Adults Attending 1 or More Treatment Appointments

measured by Health Coach report in the Health Coach logs and participant report in the STI Treatment section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Secondary

Number of STI+ Young Adults Referred to STI Treatment

measured by the Health Coach report in the Health Coach Logs and participant report in the STI Referral section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Secondary

Number of Young Adults Attending Intake Plus One Treatment Session

measured by Health Coach report in the Health Coach logs and participant report in the Substance Use Treatment section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Secondary

Number of Young Adults Referred to Substance Use Treatment

measured by Health Coach report in the Health Coach logs and participant report in the Substance Use Referral section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Other Pre-specified

Number of HIV+ Young Adults Attending at Least One Treatment Appointment

measured by Health Coach report in the Health Coach logs and participant report in the HIV Treatment section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Other Pre-specified

Number of HIV+ Young Adults Referred to HIV Treatment

measured by Health Coach report in the Health Coach logs and participant report in the HIV Referral section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Other Pre-specified

Number of Young Adults Behaviorally PrEP Eligible Attending at Least One HIV Care Appointment

measured by Health Coach report in the Health Coach logs and participant report in the PrEP Uptake section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Other Pre-specified

Number of Young Adults Behaviorally PrEP Eligible Referred to PrEP/Medical Care

measured by Health Coach report in the Health Coach logs and participant report in the PrEP Referral section of the questionnaires

Time frame: at 3-, 6-, and 12-month follow-ups

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026